Background: Endometrial cancer is a common gynecological cancer whose incidence is increasing annually worldwide. However, the biomarkers that provide the prognosis and progression of endometrial cancer are still lacking.
differentially expressed target genes. Pearson correlation analysis was then used in starBase (http://starbase.sysu.edu.cn/) to verify the association between these potentially valuable differentially expressed target genes and DEMs in patients with EC [20, 21] . These significant differentially expression target genes and corresponding miRNAs were used to construct a miRNA-mRNA regulatory network using the Cytoscape software. The Degree of interaction of the node ≥ 5 which was defined as hub miRNA.
Survival analysis of hub genes
The overall survival of patients with EC with regard to hub genes were calculated using Kaplan-Meier analysis in OncoLnc (www.oncolnc.org). The patients were divided into two (high vs. low) groups according to the median values of mRNA expression of the hub gene. The log-rank test was used to examine the significance of difference between two groups.
Results

Identification of DEGs and DEMs
A total of 1,961 DEGs and 149 DEMs were identified from GSE17025 and GSE25405, respectively; 2,339 DEGs and 205 DEMs were identified from the mRNA and miRNA data of uterine corpus endometrial carcinoma in TCGA (named TCGA-UCEC and TCGA-UCEC_miRNA, respectively); 520 common DEGs and 30 common DEMs were screened out with Venny 2.1.0 http://bioinfogp.cnb.csic.es/tools/venny/index.html) [22] , respectivly ( Fig. 1a, Fig. 1b ). there were 212 upregulated genes and 308 downregulated genes, and 15 upregulated and 15 downregulated miRNAs in EC tissues compared with NE tissues, respectively ( Table 1, Table 2 ).
Functional and pathway enrichment analysis
The functional and pathway enrichment analyses of DEGs were conducted with DAVID. The upregulated genes were mainly enriched in biological processes, which were cell cycle, cell division, and DNA replication signaling pathways, while downregulated genes were mainly enriched in skeletal system development, vasculature development, and cell adhesion signaling pathways (Table 3) . Moreover, three KEGG pathways were enriched in upregulated genes, including cell cycle, oocyte maturation, and oocyte meiosis signaling pathways (Table 3 ). There were no KEGG pathways enriched in downregulated genes.
Construction of PPI network and module analysis
A PPI network consisting of 287 nodes and 1,840 edges was constructed, which included 212 upregulated and 308 downregulated genes ( Fig. 2) . Then, 82 nodes were screened out as hub genes (Degree of interaction≥10 were selected as the threshold) [23], there were close correlations among hub genes ( Fig.3 , Additional file 1). After analyzing the network with the MCODE app in Cytoscape software, an important module was obtained, including 50 nodes and 1,082 edges ( Fig. 4 ).
Functional enrichment analyses of biological processes with regard to this module showed that these genes were enriched in cell cycle, cell division, and DNA replication signaling pathways (Table 4 ). Three KEGG pathways were enriched in cell cycle, oocyte meiosis, and oocyte maturation signaling pathways ( Table 4 ).
Analysis of miRNA-mRNA regulatory network
Thirty commonly identified DEMs were screened out from GSE25405 and TCGA-UCEC_miRNA, including 15 upregulated and 15 downregulated miRNAs ( Table 2) . based on miRecords database, 6, 865 TG-miRNAs were screened out, of which 199, were validated in 520 common DEGs (Fig. 1a ). These 199 commonly identified DEGs and 30 commonly identified DEMs were used to constructed a miRNA-mRNA network.
In patients with EC, 160 pairs of DEMs-DEGs relationships with reverse association expression were confirmed using starBase v2.0 project, including 22 DEMs and 71
overlapping DEGs (Fig. 5 , Additional file 2). In the network, hsa-miR-200b, hsa-miR-200c, hsa-miR-429, hsa-miR-424, hsa-miR-195, hsa-miR-653, and hsa-miR-141 showed a higher degree of interaction (degree of interaction ≥ 5, Table 5 ).
Survival analysis
The prognostic value of 82 hub genes were assessed in OncoLnc. Related results found that high mRNA expression of BUB1, TOP2A, CDCA8, TTK, ASPM, UBE2C, BIRC5, HJURP, CENPA, MCM10, FOXM1, SPAG5, EXO1, ESPL1, OIP5, MCM4, CDC25C, DEPDC1, KIF18B, ERCC6L, CKAP2L, ATAD2, TK1, CCNF, E2F1, and CCNE1 were associated with significantly worse overall survival for EC patients, and low expression of MYC was correlated with significantly worse overall survival in EC patients (data not shown). What makes us interesting was that CCNE1 was also identified as a target gene of hsa-miR-195 ( Fig. 6, Fig. 7 ).
Discussion
In recent years, although clinical medical scientists have made significant progress in the treatment of EC with surgery and chemotherapy, the incidence and mortality rate of EC are still increasing [24] . It is necessary to further understand the etiology and mechanism of EC progression to improve the prognosis of EC.
In this study, by integrating GSE17025 with TCGA-UCEC, 520 common DEGs were screened out in EC tissues compared with NE tissues. these 520 common DEGs were composed of 212 upregulated genes and 308 downregulated genes. These upregulated DEGs were mainly enriched in cell cycle, cell division, and DNA replication signaling pathways, while the downregulated DEGs in skeletal system development, vasculature development, and cell adhesion signaling pathways.
Following, 82 hub genes were screened out from PPI network. After analyzing the survival of these 82 hub genes, 26 upregulated genes and one downregulated gene is upregulated in many malignant tumors [28-30], and its role in the inhibition of mesenchymal characteristics and metastasis has been revealed in prostate, gastric carcinoma, and hepatocellular carcinoma by regulating the ZEB1 expression or directly targeting ZEB2 or via Rho/ROCK signaling pathway [31] [32] [33] . The current study suggested that hsa-miR-200b was also upregulated, which was consistent with the previous study [34] . Hsa-miR-200c has been widely investigated during the last few years. There have been numerous studies demonstrating the association between an aberrant expression level of miR-200c and the prognosis of various human malignancies, such as breast cancer [28, 35, 36] , prostate cancer [37] , ovarian cancer [38] , and endometrial cancer [39] . Some of these studies verified the anti-oncogenic function of miR-200c in certain cancer types, indicating the potential correlation of elevated expression levels of miR-200c and superior prognosis [36, 38, 39] . However, other studies have provided opposing evidence, suggesting that miR-200c serves as an oncogene [28, 35, 37] . These conclusions suggest that miR-200c is a notable biomarker for prognosis of cancer. Our present study suggested that hsa-miR-200c was upregulated, which was consistent with the previous study [39] . Recent reports have shown that hsa-miR-429 expression is frequently upregulated and may function as an oncogene in several cancers [40, 41] , such as endometrial carcinoma [40] , which is consistent with the finding of this study. One study showed that upregulation of hsa-miR-429 can effectively suggest a decrease in overall survival of serous ovarian cancer [42] ; in contrast, some studies have shown that hsa-miR-429 was downregulated in some malignant tumors and involved in tumor-suppressor function [43, 44] . These results indicate that hsa-miR-429 plays different (even opposite) roles in tumorigenesis and cancer progression in different tumors. Hsa-miR-141 is aslo an important member in the miR-200 family, several previous studies have shown that has-miR-141 was involved in prognosis of cancer [45] [46] [47] .
Some previous studies have found that hsa-miR-424 was downregulated and could acts as a tumor suppressor in some cancers [48] [49] [50] . Our current study showed that hsa-miR-424 was also downregulated, which was consistent with the previous study 
Conclusion
Based on bioinformatics analyses of EC-related microarray data in the GEO database and clinical data related to EC in TCGA database, we found that 27 hub genes (BUB1, TOP2A, CDCA8, TTK, ASPM, UBE2C, BIRC5, HJURP, CENPA, MCM10, FOXM1,   SPAG5, EXO1, ESPL1, OIP5, MCM4, CDC25C, DEPDC1, KIF18B, ERCC6L, CKAP2L,   ATAD2, TK1, CCNF Tables Table 1 Top Demonstration of the important module by cytoscape. The edges/lines stand for interaction r Figure 5 The miRNA-mRNA regulatory network. Green and red nodes stand for upregulation and downr Overall survival analysis of CCNE1 expression with prognosis of endometrial cancer patients The correlated expression of CCNE1 and hsa-miR-195-5p (hsa-miR-195) in 538 patients with
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